Ascletis is engaged in discovering and developing specialty therapeutics for the treatment of cancer and infectious diseases.
Business Model:
Revenue: $0
Employees: 201-500
Address: 1785 Jianghai Road,building No.1,
City: Hangzhou
State: zhejiang province
Zip: 311100
Country: CN
Ascletis is engaged in discovering and developing specialty therapeutics for the treatment of cancer and infectious diseases.
Contact Phone:
Contact Email:
Listed Exchange:
Hong Kong Stock Exchange
IPO Date:
11/19/2019
Ticker Symbol:
01672
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
2/2019 | Sagimet Biosciences | Series E | 0 |
2/2021 | Sagimet Biosciences | Venture Round | 0 |
8/2019 | Sagimet Biosciences | Series E | 0 |
2/2021 | Sagimet Biosciences | Venture Round | 0 |
8/2019 | Sagimet Biosciences | Series E | 0 |
2/2019 | Sagimet Biosciences | Series E | 0 |
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|